Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 10 | 2022 | 67 | 1.230 |
Why?
|
| Skin | 12 | 2018 | 103 | 1.070 |
Why?
|
| Skin Diseases | 7 | 2010 | 23 | 0.830 |
Why?
|
| Skin Diseases, Vascular | 4 | 2018 | 4 | 0.810 |
Why?
|
| Arthritis, Gouty | 1 | 2020 | 1 | 0.710 |
Why?
|
| Panniculitis | 1 | 2020 | 3 | 0.710 |
Why?
|
| Hemangioma | 2 | 2019 | 8 | 0.670 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2019 | 5 | 0.650 |
Why?
|
| Blastomyces | 1 | 2018 | 9 | 0.620 |
Why?
|
| Blastomycosis | 1 | 2018 | 20 | 0.610 |
Why?
|
| Pyoderma Gangrenosum | 2 | 2007 | 3 | 0.540 |
Why?
|
| Dermatologic Agents | 2 | 2008 | 7 | 0.500 |
Why?
|
| Antiphospholipid Syndrome | 2 | 2008 | 5 | 0.480 |
Why?
|
| Vasculitis | 3 | 2018 | 26 | 0.430 |
Why?
|
| Sweet Syndrome | 3 | 2006 | 3 | 0.420 |
Why?
|
| Multiple Myeloma | 2 | 2010 | 21 | 0.410 |
Why?
|
| Humans | 43 | 2022 | 25964 | 0.400 |
Why?
|
| Amyloidosis | 2 | 2010 | 26 | 0.370 |
Why?
|
| Dapsone | 2 | 2008 | 3 | 0.340 |
Why?
|
| Lipectomy | 1 | 2009 | 1 | 0.330 |
Why?
|
| Back | 1 | 2009 | 2 | 0.330 |
Why?
|
| Lipomatosis | 1 | 2009 | 3 | 0.330 |
Why?
|
| Abdomen | 1 | 2009 | 8 | 0.330 |
Why?
|
| Extremities | 1 | 2009 | 27 | 0.320 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 1 | 0.320 |
Why?
|
| Acne Vulgaris | 1 | 2008 | 3 | 0.320 |
Why?
|
| Anemia, Hemolytic | 1 | 2008 | 4 | 0.320 |
Why?
|
| Lymphoma | 3 | 2007 | 36 | 0.320 |
Why?
|
| Male | 19 | 2022 | 13980 | 0.310 |
Why?
|
| Drug Eruptions | 2 | 2007 | 9 | 0.310 |
Why?
|
| Photochemotherapy | 2 | 2022 | 4 | 0.300 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 2 | 2022 | 7 | 0.300 |
Why?
|
| Pseudolymphoma | 1 | 2007 | 1 | 0.290 |
Why?
|
| Adult | 12 | 2022 | 7349 | 0.270 |
Why?
|
| Hand Dermatoses | 1 | 2006 | 1 | 0.260 |
Why?
|
| Diagnosis, Differential | 9 | 2018 | 342 | 0.260 |
Why?
|
| Mycosis Fungoides | 2 | 2022 | 6 | 0.230 |
Why?
|
| Thrombomodulin | 2 | 2001 | 2 | 0.230 |
Why?
|
| Middle Aged | 12 | 2022 | 8507 | 0.230 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2000 | 7 | 0.220 |
Why?
|
| Female | 19 | 2022 | 14347 | 0.200 |
Why?
|
| Meningococcal Infections | 1 | 2001 | 1 | 0.200 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 37 | 0.190 |
Why?
|
| Blood Coagulation Factors | 1 | 2001 | 17 | 0.190 |
Why?
|
| Tretinoin | 2 | 1994 | 14 | 0.190 |
Why?
|
| Antimalarials | 1 | 2001 | 8 | 0.180 |
Why?
|
| Hemangiosarcoma | 1 | 2001 | 8 | 0.180 |
Why?
|
| Facial Dermatoses | 1 | 2000 | 1 | 0.180 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 4 | 0.180 |
Why?
|
| Myeloproliferative Disorders | 1 | 2000 | 3 | 0.180 |
Why?
|
| Thrombophilia | 1 | 2000 | 5 | 0.180 |
Why?
|
| Hematologic Diseases | 2 | 1990 | 11 | 0.170 |
Why?
|
| Thorax | 1 | 2019 | 11 | 0.160 |
Why?
|
| Disease | 1 | 1998 | 5 | 0.160 |
Why?
|
| Biopsy | 7 | 2006 | 199 | 0.150 |
Why?
|
| Adolescent | 5 | 2009 | 2062 | 0.130 |
Why?
|
| Leg Ulcer | 2 | 1998 | 4 | 0.130 |
Why?
|
| Scleroderma, Localized | 3 | 1998 | 5 | 0.120 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2008 | 25 | 0.120 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1994 | 4 | 0.110 |
Why?
|
| Purpura | 1 | 1994 | 2 | 0.110 |
Why?
|
| Child | 4 | 2008 | 1226 | 0.100 |
Why?
|
| Syndrome | 3 | 2009 | 73 | 0.100 |
Why?
|
| Immunoglobulin A | 2 | 1989 | 13 | 0.100 |
Why?
|
| Aged | 8 | 2010 | 8703 | 0.100 |
Why?
|
| Skin Diseases, Vesiculobullous | 2 | 1988 | 12 | 0.100 |
Why?
|
| Leukapheresis | 1 | 1991 | 1 | 0.090 |
Why?
|
| Candidiasis, Cutaneous | 1 | 2010 | 1 | 0.090 |
Why?
|
| Neutrophils | 2 | 2006 | 96 | 0.090 |
Why?
|
| Lupus Erythematosus, Discoid | 2 | 1987 | 9 | 0.090 |
Why?
|
| Prednisone | 2 | 2007 | 61 | 0.090 |
Why?
|
| Hyperplasia | 1 | 2009 | 13 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 59 | 0.080 |
Why?
|
| Protein C | 2 | 2001 | 8 | 0.080 |
Why?
|
| Hemoglobins | 1 | 2008 | 74 | 0.080 |
Why?
|
| Xanthomatosis | 3 | 1998 | 3 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2008 | 398 | 0.070 |
Why?
|
| Sarcoma, Kaposi | 1 | 1987 | 3 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1987 | 35 | 0.070 |
Why?
|
| Leg | 1 | 2007 | 48 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 74 | 0.070 |
Why?
|
| Paraproteinemias | 1 | 1986 | 6 | 0.070 |
Why?
|
| Fasciitis | 1 | 1985 | 1 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2006 | 62 | 0.060 |
Why?
|
| Eosinophilia | 1 | 1985 | 35 | 0.060 |
Why?
|
| Young Adult | 1 | 2008 | 1848 | 0.050 |
Why?
|
| Ointments | 1 | 2022 | 1 | 0.050 |
Why?
|
| Perylene | 1 | 2022 | 1 | 0.050 |
Why?
|
| Anthracenes | 1 | 2022 | 6 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2022 | 4 | 0.050 |
Why?
|
| Endothelium | 1 | 2001 | 11 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1998 | 189 | 0.050 |
Why?
|
| Quinacrine | 1 | 2001 | 1 | 0.050 |
Why?
|
| Hemangioendothelioma | 1 | 2001 | 3 | 0.050 |
Why?
|
| Chloroquine | 1 | 2001 | 6 | 0.050 |
Why?
|
| Protein S Deficiency | 1 | 2000 | 1 | 0.050 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2000 | 2 | 0.050 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2000 | 1 | 0.040 |
Why?
|
| Capillaries | 1 | 2000 | 11 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2001 | 63 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2000 | 79 | 0.040 |
Why?
|
| Erythema Multiforme | 1 | 1998 | 1 | 0.040 |
Why?
|
| Erythema Nodosum | 1 | 1998 | 1 | 0.040 |
Why?
|
| Rosacea | 1 | 1998 | 1 | 0.040 |
Why?
|
| Dermatitis, Seborrheic | 1 | 1998 | 1 | 0.040 |
Why?
|
| Tinea Versicolor | 1 | 1998 | 1 | 0.040 |
Why?
|
| Vitiligo | 1 | 1998 | 1 | 0.040 |
Why?
|
| Flushing | 1 | 1998 | 2 | 0.040 |
Why?
|
| Porphyria Cutanea Tarda | 1 | 1998 | 2 | 0.040 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 1998 | 2 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cellulitis | 1 | 1998 | 8 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1989 | 55 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 1998 | 8 | 0.040 |
Why?
|
| Dermatomyositis | 1 | 1998 | 11 | 0.040 |
Why?
|
| Dermatology | 1 | 1998 | 5 | 0.040 |
Why?
|
| Sarcoidosis | 1 | 1998 | 12 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 1998 | 56 | 0.040 |
Why?
|
| Prognosis | 1 | 2001 | 749 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2018 | 30 | 0.040 |
Why?
|
| Plasmacytoma | 2 | 1989 | 8 | 0.040 |
Why?
|
| Necrosis | 3 | 2000 | 26 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 83 | 0.040 |
Why?
|
| Primary Health Care | 1 | 1998 | 90 | 0.040 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1997 | 8 | 0.040 |
Why?
|
| Leukemic Infiltration | 1 | 1994 | 1 | 0.030 |
Why?
|
| Photopheresis | 1 | 1994 | 1 | 0.030 |
Why?
|
| Erythema | 1 | 1994 | 2 | 0.030 |
Why?
|
| Keratinocytes | 1 | 1994 | 12 | 0.030 |
Why?
|
| Risk Factors | 1 | 2000 | 2240 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 1994 | 24 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 3292 | 0.030 |
Why?
|
| Graft Rejection | 1 | 1994 | 63 | 0.030 |
Why?
|
| Hemorrhage | 1 | 1994 | 75 | 0.030 |
Why?
|
| Lipoma | 1 | 1991 | 6 | 0.020 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 1990 | 1 | 0.020 |
Why?
|
| Histiocytosis, Non-Langerhans-Cell | 1 | 1990 | 3 | 0.020 |
Why?
|
| Granuloma | 2 | 1992 | 13 | 0.020 |
Why?
|
| Hemoglobinopathies | 1 | 1990 | 1 | 0.020 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1990 | 1 | 0.020 |
Why?
|
| Histiocytosis, Langerhans-Cell | 2 | 1988 | 2 | 0.020 |
Why?
|
| Leukemia | 1 | 1989 | 4 | 0.020 |
Why?
|
| Histiocytic Sarcoma | 1 | 1989 | 3 | 0.020 |
Why?
|
| Bromocriptine | 1 | 1989 | 5 | 0.020 |
Why?
|
| Basement Membrane | 1 | 1988 | 11 | 0.020 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 1988 | 1 | 0.020 |
Why?
|
| Transfusion Reaction | 1 | 1988 | 6 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 534 | 0.020 |
Why?
|
| Parvoviridae Infections | 1 | 1988 | 1 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1989 | 100 | 0.020 |
Why?
|
| Isotretinoin | 1 | 1987 | 8 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1987 | 10 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 1987 | 11 | 0.020 |
Why?
|
| Risk | 1 | 1987 | 197 | 0.020 |
Why?
|
| Mast Cells | 1 | 1986 | 16 | 0.020 |
Why?
|
| Myxedema | 1 | 1986 | 1 | 0.020 |
Why?
|
| Purpura, Hyperglobulinemic | 1 | 1986 | 1 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 1986 | 2 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1986 | 20 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1986 | 27 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 1985 | 6 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 1985 | 12 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 1987 | 120 | 0.020 |
Why?
|
| Seizures | 1 | 1985 | 63 | 0.020 |
Why?
|
| Epidermis | 2 | 1994 | 5 | 0.010 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2000 | 9 | 0.010 |
Why?
|
| Forecasting | 1 | 1998 | 91 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1994 | 124 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1994 | 264 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1994 | 475 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1994 | 281 | 0.010 |
Why?
|
| Giant Cells | 1 | 1992 | 2 | 0.010 |
Why?
|
| Histiocytes | 1 | 1992 | 4 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1992 | 71 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1992 | 59 | 0.010 |
Why?
|
| Eosinophils | 1 | 1992 | 42 | 0.010 |
Why?
|
| Desmin | 1 | 1991 | 1 | 0.010 |
Why?
|
| Factor VIIIa | 1 | 1991 | 1 | 0.010 |
Why?
|
| S100 Proteins | 1 | 1991 | 4 | 0.010 |
Why?
|
| Ear, External | 1 | 1991 | 2 | 0.010 |
Why?
|
| Myoglobin | 1 | 1991 | 2 | 0.010 |
Why?
|
| Ear Neoplasms | 1 | 1991 | 7 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1991 | 335 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 1989 | 1 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1988 | 47 | 0.000 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 1988 | 1 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1988 | 7 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1988 | 64 | 0.000 |
Why?
|
| Langerhans Cells | 1 | 1986 | 1 | 0.000 |
Why?
|
| Urticaria Pigmentosa | 1 | 1986 | 1 | 0.000 |
Why?
|
| Urticaria | 1 | 1986 | 3 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1986 | 15 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1986 | 65 | 0.000 |
Why?
|